59 related articles for article (PubMed ID: 17009957)
1. Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives.
Kozlov MV; Polyakov KM; Ivanov AV; Filippova SE; Kuzyakin AO; Tunitskaya VL; Kochetkov SN
Biochemistry (Mosc); 2006 Sep; 71(9):1021-6. PubMed ID: 17009957
[TBL] [Abstract][Full Text] [Related]
2. RNA-dependent RNA polymerase of hepatitis C virus: study on inhibition by alpha,gamma-diketo acid derivatives.
Kozlov MV; Polyakov KM; Filippova SE; Evstifeev VV; Lyudva GS; Kochetkov SN
Biochemistry (Mosc); 2009 Aug; 74(8):834-41. PubMed ID: 19817682
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
[TBL] [Abstract][Full Text] [Related]
5. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.
Howe AY; Cheng H; Thompson I; Chunduru SK; Herrmann S; O'Connell J; Agarwal A; Chopra R; Del Vecchio AM
Antimicrob Agents Chemother; 2006 Dec; 50(12):4103-13. PubMed ID: 16940072
[TBL] [Abstract][Full Text] [Related]
7. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
[TBL] [Abstract][Full Text] [Related]
10. New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Ivanov AV; Kozlov MV; Kuzyakin AO; Kostyuk DA; Tunitskaya VL; Kochetkov SN
Biochemistry (Mosc); 2004 Jul; 69(7):782-8. PubMed ID: 15310279
[TBL] [Abstract][Full Text] [Related]
11. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
[TBL] [Abstract][Full Text] [Related]
12. The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds.
Tramontano E
Mini Rev Med Chem; 2008 Oct; 8(12):1298-310. PubMed ID: 18855743
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture.
Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Baker A; Earnshaw DL; Hofmann GA; Keenan RM; Dhanak D
Bioorg Med Chem Lett; 2005 Mar; 15(6):1553-6. PubMed ID: 15745795
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.
Tomei L; Altamura S; Bartholomew L; Bisbocci M; Bailey C; Bosserman M; Cellucci A; Forte E; Incitti I; Orsatti L; Koch U; De Francesco R; Olsen DB; Carroll SS; Migliaccio G
J Virol; 2004 Jan; 78(2):938-46. PubMed ID: 14694125
[TBL] [Abstract][Full Text] [Related]
15. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors.
Di Santo R; Fermeglia M; Ferrone M; Paneni MS; Costi R; Artico M; Roux A; Gabriele M; Tardif KD; Siddiqui A; Pricl S
J Med Chem; 2005 Oct; 48(20):6304-14. PubMed ID: 16190757
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
Kim J; Kim KS; Kim DE; Chong Y
Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
[TBL] [Abstract][Full Text] [Related]
17. Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.
Mo H; Lu L; Pilot-Matias T; Pithawalla R; Mondal R; Masse S; Dekhtyar T; Ng T; Koev G; Stoll V; Stewart KD; Pratt J; Donner P; Rockway T; Maring C; Molla A
Antimicrob Agents Chemother; 2005 Oct; 49(10):4305-14. PubMed ID: 16189112
[TBL] [Abstract][Full Text] [Related]
18. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
[TBL] [Abstract][Full Text] [Related]
19. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
[TBL] [Abstract][Full Text] [Related]
20. RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities.
May MM; Lorengel H; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
Biochim Biophys Acta; 2011 Oct; 1814(10):1325-32. PubMed ID: 21621653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
